Yajie Niu
Chief Science Officer at Invaio
Cambridge, Massachusetts
Overview
Work Experience
Chief Science Officer
2023 - Current
Head of Technologies
2022 - 2023
Head of External Technologies Innovation
2022 - 2022
Head Of Research
2020 - 2022
Invaio Sciences is a technology company that is dedicated to solving pressing agriculture, nutrition, and environmental challenges.
Raised $138,900,000.00 from K2 HealthVentures.
Principal
2021 - 2022
Senior Associate
2019 - 2021
Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.
Senior Director of Research Development
2017 - 2019
• Developed proprietary CRISPR tools for gene modulation • Developed and implemented high-throughput cell screening platform that enables fast validation and discovery of target leads • Implemented next generation sequencing and data analysis pipeline for efficient molecular readout and phenotyping • Supported technology and products intellectual property development
Director Of Research Development
2017 - 2017
Inari is a biotechnology company that aims to transform agriculture and its impact on society and the environment.
Raised $609,000,000.00 from Flagship Pioneering, Rokos Capital Management, State of Michigan Retirement System, Hanwha Impact Partners, Rivas Capital, NGS Super and CPP Investments.
Senior Scientist
2016 - 2017
Research Fellow
2009 - 2016
Employed integrative and novel approaches in molecular biology, functional genomics, chemical genetics, biochemistry and computational biology to: • Design and develop methodologies in calcium imaging, including construction of an ultrasensitive Ca2+ biosensor GCaMP6S and development of a leaf single-cell system for live GCaMP6S-based Ca2+ imaging • Uncover a unique temporal Ca2+ signal in nutrient signaling pathway • Develop and optimize cell-based functional genomic screen to identify different Ca2+ sensor kinases in plant immune, hormone, stress and nutrient signaling pathways • Apply protein engineering and chemical genetics to circumvent embryo lethality and functional redundancy of Ca2+ sensor kinases • Develop and optimize artificial miRNA gene-silencing, RNA-seq, MS phosphoproteomics to link Ca2+ sensor kinases to diverse intracellular effectors
Education
Doctor of Philosophy (Ph.D.)
2004 - 2009
BS
1999 - 2003